By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Drugs A-Z > SSRI antidepressant > Escitalopram

Escitalopram

GMJ
Last updated: 02/06/2026 14:31
By
Prof. Giorgi Pkhakadze
Share
5 Min Read
SHARE
3 min read|642 words

Escitalopram: A Comprehensive Drug Profile

What is Escitalopram?

Escitalopram is a prescription antidepressant medication belonging to a class of drugs called selective serotonin reuptake inhibitors (SSRIs). It is primarily used to treat major depressive disorder and generalized anxiety disorder by helping to restore the balance of serotonin, a natural chemical in the brain. Escitalopram is considered one of the most selective SSRIs available, meaning it has fewer interactions with other neurotransmitter systems.

Uses

Escitalopram has several FDA-approved and well-documented clinical uses:

  • Major Depressive Disorder: The primary indication for treating episodes of depression characterized by persistent sadness, loss of interest, and other depressive symptoms
  • Generalized Anxiety Disorder: Helps manage excessive worry, anxiety, and physical symptoms of anxiety that interfere with daily functioning
  • Panic Disorder: Often prescribed off-label to reduce the frequency and intensity of panic attacks
  • Social Anxiety Disorder: Used to treat intense fear and avoidance of social situations
  • Obsessive-Compulsive Disorder: May be prescribed off-label to help reduce obsessive thoughts and compulsive behaviors

How it works

Escitalopram works by blocking the reuptake of serotonin in the brain, which increases the amount of this neurotransmitter available between nerve cells. Serotonin plays a crucial role in regulating mood, anxiety, and other emotional states. By maintaining higher levels of serotonin in the synaptic gaps between neurons, escitalopram helps improve communication in brain circuits involved in mood regulation and can reduce symptoms of depression and anxiety over time.

Side effects

Common side effects include:

Submit Your Paper
GMJ_Submit_Banner
  • Nausea and digestive upset
  • Headache
  • Drowsiness or fatigue
  • Insomnia or sleep disturbances
  • Dry mouth
  • Dizziness
  • Sexual dysfunction or decreased libido
  • Increased sweating

Serious side effects to watch for:

  • Suicidal thoughts or behaviors, especially in young adults
  • Serotonin syndrome (confusion, rapid heart rate, high fever, muscle rigidity)
  • Abnormal bleeding or bruising
  • Severe allergic reactions
  • Manic episodes in people with bipolar disorder

Warnings and precautions

  • Suicide risk: Escitalopram carries a black box warning for increased suicide risk in children, adolescents, and young adults under 25, particularly during the first few weeks of treatment
  • Pregnancy considerations: Classified as FDA pregnancy category C; potential risks to the developing fetus must be weighed against maternal benefits
  • Withdrawal symptoms: Discontinuation should be gradual under medical supervision to avoid withdrawal effects such as dizziness, flu-like symptoms, and brain zaps
  • Heart conditions: May cause QT interval prolongation; use caution in patients with heart rhythm disorders
  • Liver impairment: Dosage adjustments may be necessary for patients with severe liver problems

Interactions

Escitalopram has several important drug and supplement interactions:

  • MAO inhibitors: Dangerous interaction that can cause serotonin syndrome; requires 14-day washout period
  • Blood thinners (warfarin): Increased bleeding risk due to effects on platelet function
  • NSAIDs and aspirin: May increase risk of bleeding, especially gastrointestinal bleeding
  • Other serotonergic medications: Including tramadol, triptans, and other antidepressants can increase serotonin syndrome risk
  • St. John’s Wort: May increase serotonin levels and reduce escitalopram effectiveness
  • Cimetidine: Can increase escitalopram blood levels by inhibiting its metabolism
  • QT-prolonging drugs: May increase risk of heart rhythm abnormalities
  • Lithium: Combination may increase serotonin-related side effects

Check interactions with the GMJ Interaction Checker

Dosage

Typical adult dosing for escitalopram varies based on the condition being treated. For major depressive disorder, the usual starting dose is 10 mg once daily, which may be increased to a maximum of 20 mg daily after at least one week. For generalized anxiety disorder, the recommended dose is 10 mg once daily. Elderly patients typically start with 5 mg daily due to increased sensitivity. The medication can be taken with or without food, preferably at the same time each day. Dosage adjustments should always be made under the guidance of a healthcare provider, who will consider individual patient factors, response to treatment, and any side effects experienced.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

Cite this page

GMJ News Desk. "Escitalopram." GMJ News — Georgian Medical Journal, 2 June 2026. https://news.gmj.ge/drug/escitalopram/

CC BY 4.0This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).

Was this article helpful?

Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Evidence review: Which supplements older adults actually need and which ones to avoid

New evidence shows older adults benefit more from targeted supplementation for specific…

Traditional Chinese herb shows promise for androgenetic alopecia treatment

Traditional Chinese herb Polygonum multiflorum shows promise for treating androgenetic alopecia through…

Dual Doctor Couples Face Amplified Childcare Crisis in Medical Training

Dual doctor couples face amplified childcare challenges during medical training, with foundation…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Fluvoxamine

By
Prof. Giorgi Pkhakadze
02/06/2026

Paroxetine

By
Prof. Giorgi Pkhakadze
02/06/2026

Citalopram

By
Prof. Giorgi Pkhakadze
02/06/2026

Fluoxetine

By
Prof. Giorgi Pkhakadze
02/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up